Why the study?
Insulin resistance contributes to adverse cardiovascular outcomes, but conventional assessments are complex and not routinely available. This study evaluated whether the estimated glucose disposal rate (eGDR), a simple surrogate of insulin resistance, provides prognostic information in patients with established CVD.
Does a higher estimated glucose disposal rate (eGDR) predict lower all-cause and cardiovascular mortality in adults with established cardiovascular disease?
Cohort (n=35,743)
Yes
Does a higher estimated glucose disposal rate (eGDR) predict lower all-cause and cardiovascular mortality in adults with established cardiovascular disease?
Answers are grounded in this paper and cite their sources.
Estimated glucose disposal rate (eGDR), calculated from routine clinical variables (waist circumference, hypertension status, and HbA1c), independently predicts all-cause and cardiovascular mortality in patients with established CVD across two large cohorts.
Background Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide. Insulin resistance contributes to adverse cardiovascular outcomes but conventional assessments are complex and not routinely available. The estimated glucose disposal rate (eGDR), a simple surrogate of insulin resistance, may provide prognostic information in patients with established CVD.Methods Adults with CVD were identified from the National Health and Nutrition Examination Survey (NHANES) (n=4283) as the primary cohort and from a predefined UK Biobank (UKB) subcohort (n=31 460) as the replication cohort. Cox models, restricted cubic splines, Kaplan-Meier curves and subgroup analyses were used to evaluate associations between eGDR and mortality.Results During median follow-ups of 7.8 and 14.2 years, 1886 and 2218 deaths occurred in NHANES and the UKB, including 634 and 616 cardiovascular deaths, respectively. In fully adjusted models, higher continuous eGDR was associated with lower all-cause mortality in NHANES (HR, 0.859; 95% CI 0.800 to 0.923; p<0.001) and the UKB (HR, 0.792; 95% CI 0.743 to 0.844; p<0.001). Similar associations were observed for cardiovascular mortality in NHANES (HR, 0.844; 95% CI 0.736 to 0.969; p=0.016) and the UKB (HR, 0.737; 95% CI 0.656 to 0.828; p<0.001). Spline analyses showed non-linear inverse associations with both mortality outcomes in NHANES. In the UKB, the association with all-cause mortality became non-linear after multivariable adjustment, whereas the association with cardiovascular mortality was approximately linear.Conclusion Higher eGDR was independently associated with lower all-cause and cardiovascular mortality in patients with CVD, supporting its potential as a simple marker for mortality risk stratification.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) conducted a cohort in Cardiovascular disease (n=35,743). Estimated glucose disposal rate (eGDR) vs. Lower eGDR (continuous per unit increase or lowest quartile Q1 as reference) was evaluated on All-cause mortality (primary cohort NHANES, continuous eGDR in fully adjusted model) (HR 0.859, 95% CI 0.800 to 0.923, p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: